A CRISPR kidney that is part pig, part person is just another step toward editing our children’s genes. Call it sci-fi ...

Researchers at the Salk Institute have used CRISPR to uncover hidden microproteins that control fat cell growth and lipid ...

The obesity rate has more than doubled in the last 30 years, affecting more than one billion people worldwide.

The obesity rate has more than doubled in the last 30 years, affecting more than one billion people worldwide. This prevalent ...

Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Researchers developed a method to dissect immune-regulatory programs via integrative time-series analysis and high-content CRISPR screening.

Mars, maker of M&M's and Skittles, is turning to CRISPR gene editing to develop more resilient cacao plants, with the aim of ...

CRISPR Therapeutics, trading under, operates within the biotechnology sector, a key area of interest within the broader ...

The obesity rate has more than doubled in the last 30 years, affecting more than one billion people worldwide. This prevalent ...

CRISPR Therapeutics (CRSP) stock falls as company's Q2 results miss consensus amid focus on its Cagevy gene therapy developed with Vertex Pharma (VRTX). Read more here.

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.